Federation Des Caisses Desjardins Du Quebec Eagle Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 30, 2024
SELL
$51.25 - $76.62 $165,588 - $247,559
-3,231 Closed
0 $0
Q1 2018

Aug 30, 2024
SELL
$52.16 - $66.86 $58,836 - $75,418
-1,128 Reduced 25.88%
3,231 $170 Million
Q3 2017

Aug 30, 2024
BUY
$46.62 - $60.36 $83,496 - $108,104
1,791 Added 69.74%
4,359 $260 Million
Q2 2017

Aug 30, 2024
BUY
N/A
2,568
2,568 $203 Million

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $6.77M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email